Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2004. Upgrade now.
Date Value
June 30, 2023 -4.987B
March 31, 2023 -4.203B
December 31, 2022 -3.532B
September 30, 2022 -4.783B
June 30, 2022 -4.871B
March 31, 2022 -4.752B
December 31, 2021 -5.029B
September 30, 2021 -3.684B
June 30, 2021 -3.957B
March 31, 2021 -3.691B
December 31, 2020 -3.438B
September 30, 2020 -1.987B
June 30, 2020 -1.357B
March 31, 2020 -1.576B
December 31, 2019 -1.726B
September 30, 2019 -1.905B
June 30, 2019 -1.975B
March 31, 2019 -1.949B
December 31, 2018 -1.914B
September 30, 2018 -1.706B
June 30, 2018 -1.611B
March 31, 2018 -1.326B
December 31, 2017 -1.000B
September 30, 2017 -939.19M
June 30, 2017 -1.009B
Date Value
March 31, 2017 -870.94M
December 31, 2016 -1.009B
September 30, 2016 -1.307B
June 30, 2016 -1.398B
March 31, 2016 -1.424B
December 31, 2015 -907.22M
September 30, 2015 -490.48M
June 30, 2015 -187.47M
March 31, 2015 -165.51M
December 31, 2014 -368.14M
September 30, 2014 -180.14M
June 30, 2014 -348.92M
March 31, 2014 -347.84M
December 31, 2013 -493.76M
September 30, 2013 -691.26M
June 30, 2013 -630.28M
March 31, 2013 -534.54M
December 31, 2012 -702.86M
September 30, 2012 -882.14M
June 30, 2012 -700.34M
March 31, 2012 -864.76M
December 31, 2011 -646.16M
September 30, 2011 -827.89M
June 30, 2011 -867.50M
March 31, 2011 -952.61M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-5.029B
Minimum
Dec 2021
-1.357B
Maximum
Jun 2020
-3.380B
Average
-3.684B
Median
Sep 2021

Cash from Investing (TTM) Benchmarks

Eli Lilly and Co -7.642B
Amgen Inc -27.78B
Genmab A/S -394.15M
Ascendis Pharma A/S 91.67M